Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma

Cancer Letters

Volumn 283, Issue 1, 2009, Pages 59-67

  Zhang, Tao ^a   Zheng, Jingcun ^b   Jiang, Ning ^b   Wang, Guozeng ^b   Shi, Quan ^b   Liu, Chunfang ^a   Lu, Yuan ^a  

^a FUDAN UNIVERSITY   (China)

^b Gongli Hospital   (China)

Author keywords

Apoptosis; Cell cycle; DLC 1; Migration; RCC

Indexed keywords

CASPASE 3; CYCLIN D1; CYCLIN E; DELETED IN LIVER CANCER PROTEIN 1; FOCAL ADHESION KINASE; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P27; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CASPASE 3; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; CYCLIN E; FLOW CYTOMETRY; FOCAL ADHESION KINASE 1; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MICE; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 67650395349     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.03.025     Document Type: Article

References (24)

1. Golimbu M., Joshi P., Sperber A., Tessler A., Al-Askari S., and Morales P. Renal cell carcinoma: survival and prognostic factors. Urology 27 (1986) 291-301
2. Yuan B.Z., Miller M.J., Keck C.L., Zimonjic D.B., Thorgeirsson S.S., and Popescu N.C. Cloning characterization and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res. 58 (1998) 2196-2199
3. Durkin M.E., Avner M.R., Huh C.G., Z Yuan B., Thorgeirsson S.S., and Popescu N.C. DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development. FEBS Lett. 579 (2005) 1191-1196
4. Ng I.O., Liang Z.D., Cao L., and Lee T.K. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res. 60 (2000) 6581-6584
5. Schlaepfer D.D., Hauck C.R., and Sieg D.J. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71 (1999) 435-478
6. Kiely P.A., Leahy M., O'Gorman D., and O'Connor R. RACK1-mediated integration of adhesion and insulin like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. J. Biol. Chem. 280 (2005) 7624-7633
7. Wozniak M.A., Modzelewska K., wong L.K., and Keely P.J. Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta. 1692 (2004) 103-119
8. Ullmannova V., and Popescu N.C. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detect. Prev. 31 (2007) 110-118
9. Syed V., Mukherjee K., Lyons-Weiler J., Lau K.M., Mashima T., Tsuruo T., and Ho S.M. Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24 (2005) 1774-1787
10. Tyagi A., Agarwal C., Harrison G., Glode L.M., and Agarwal R. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis 25 (2004) 1711-1720
11. Abe H., Kamai T., Tsujii T., Nakamura F., Mashidori T., Mizuno T., Tanaka M., Tatsumiya K., Furuya N., Masuda A., Yamanishi T., and Yoshida K. Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma. Biomed. Res. 29 (2008) 155-161
12. O'Sullivan G.C., Tangney M., Casey G., Ambrose M., Houston A.., and Barry O.P. Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma. Int. J. Cancer 121 (2007) 1930-1940
13. Sgambato A., Cittadini A., Faraglia B., and Weinstein I.B. Multiple functions of p27 (Kip1) and its alterations in tumor cells: a review. J. Cell Physiol. 183 (2000) 18-27
14. Kothapalli D., Zhao L., Hawthore E.A., Cheng Y., Lee E., Pure E., and Assoian R.K. Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells. J. Cell Biol. 176 (2007) 535-544
15. Lloyd R.V., Erickson L.A., Jin L., Kulig E., Qian X., Cheville J.C., and Scheithauer B.W. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 154 (1999) 313-323
16. Wong C.M., Yam J.W., Ching Y.P., Yau T.O., Leung T.H., Jin D.Y., and Ng I.O. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res. 65 (2005) 8861-8868
17. Goodison S., Yuan J., Sloan D., Kim R., Li C., Popescu N.C., and Urquidi V. The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Res. 65 (2005) 6042-6053
18. Hood J.D., and Cheresh D.A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2 (2002) 91-100
19. Khyrul W.A., Lalonde D.P., Brown M.C., Levinson H., and Turner C.E. The integrin-linked kinase regulates cell morphology and motility in a Rho-associated kinase-dependent manner. J. Biol. Chem. 279 (2007) 54131-54139
20. Hofmockel G., Tsatalpas P., Muller H., Dammrich J., Poot M., Maurer-Schultze B., Muller-Hermelink H.K., Frohmuller H.G., and Bassukas I.D. Significance of conventional and new prognostic factors forlocally confined renal cell carcinoma. Cancer 76 (1995) 296-306
21. Visapaa H., Bui M., Huang Y., Seligson D., Tsai H., Pantuck A., Figlin R., Rao J.Y., Belldegrun A., Horvath S., and Palotie A. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology 61 (2003) 845-850
22. Ogata S., Takeuchi M., Okumura K., and Taguchi H. Apoptosis induced by niacin-related compounds in HL-60 cells. Biosci. Biotechnol. Biochem. 62 (1998) 2351-2356
23. Hockenbery D.M., Zutter M., Hickey W., Nahm M., and Korsmeyer S.J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88 (1991) 6961-6965
24. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74 (1993) 609-619